TGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma.
Marcus A AlvarezJúlia Pedó FreitasS Mazher HussainEvan S GlazerPublished in: Journal of gastrointestinal cancer (2019)
This review clarifies the recent literature investigating the role of anti-TGF-β-based therapy in PDAC and areas ripe for targeted investigations and therapies.